Editorial: Non-insulin hypoglycemic drugs in type 2 diabetes remission

Front Endocrinol (Lausanne). 2023 Oct 31:14:1325071. doi: 10.3389/fendo.2023.1325071. eCollection 2023.
No abstract available

Keywords: T2DM; diabetes; diabetes remission; glycemic control; hypoglycemic drugs.

Publication types

  • Editorial

MeSH terms

  • Blood Glucose
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glycated Hemoglobin
  • Humans
  • Hypoglycemic Agents / therapeutic use

Substances

  • Hypoglycemic Agents
  • Blood Glucose
  • Glycated Hemoglobin

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.